checkAd

    Vielleicht ein Aufsteiger? - 500 Beiträge pro Seite

    eröffnet am 15.09.09 19:34:07 von
    neuester Beitrag 08.01.10 13:06:19 von
    Beiträge: 7
    ID: 1.153.042
    Aufrufe heute: 0
    Gesamt: 799
    Aktive User: 0

    ISIN: US0016301022 · WKN: A0CADN
    0,0300
     
    USD
    -4,46 %
    -0,0014 USD
    Letzter Kurs 08.11.22 Nasdaq OTC

    Werte aus der Branche Telekommunikation

    WertpapierKursPerf. %
    0,6563+32,53
    0,6250+20,19
    0,5780+15,14
    700,65+10,21
    1,0900+10,10
    WertpapierKursPerf. %
    1,0950-8,75
    0,9525-9,72
    0,5766-9,91
    3,3200-13,54
    4,5000-25,00

     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 15.09.09 19:34:07
      Beitrag Nr. 1 ()
      Verfolge die Aktie schon seit längerem und hab sie nur im Musterdepot (leider??)!
      Hab am 08.10.2008 mal 1000K mit 0,001 € ins Musterdepot eingestellt! (Preis zu dieser Zeit)
      Heute steht sie bei 0,144 € in FFM!
      Theoretischer Gewinn 143.000,- :cry:
      Aber bisher hab ich auch noch nie Umsätze in D gesehen!:confused:

      Gestern dann diese Meldung:

      Patent Application Approval for Remote Monitoring Of Patient’s Use Of Nebulizer Compressors
      Facilitates Enhanced Coordination of Care for Patients With Respiratory Disease

      Atlanta, Georgia; September 14, 2009 – ALR Technologies (OTCBB: ALRT) announces that it has received notice from the US Patent and Trademark Office that ALRT has been granted approval of its patent application regarding patient compliance and remote monitoring of patient's use of nebulizer compressors. This approval from the US patent office will protect ALRT's Health-E-Connect health management communications system and more importantly, will grant ALRT the exclusive ability to remotely monitor the use of nebulizer compressors in the delivery of medications to patients with COPD, chronic asthma and cystic fibrosis.

      COPD is one of the leading causes of death in the world. With 16 million people in the US with COPD and 20 million plus with asthma, utilizing ALRT's Health-E-Connect system to monitor their use of nebulizer compressor creates the opportunity to significantly improve quality of life and reduce healthcare costs. Health Professionals will now be able to remotely monitor and evaluate compliance in delivery of aerosolized medications to their patients with respiratory diseases thereby helping these patients to reduce health complications and improve their quality of life.

      The use of monitoring-ready nebulizer compressors and ALRT's Health-E-Connect health management communications system can become an important new service provided by health professionals. Furthermore, the Health-E-Connect system is on target with the growing recognition in the US to use electronic health records to improve efficiency and effectiveness of patient care.

      ALRT announced earlier this year that insurance carriers will reimburse physicians for the remote care of patients with the use of its Health-E-Connect system. This will result in new revenue for physicians as they provide the additional service to their patients with respiratory disease. ALRT's Health-E-Connect and complementary Constant Health Companion is the only system in the US and International markets that allows for remote monitoring of patients' use of nebulizer compressors. This capability will allow for enhanced patient compliance and health professional coordination of care.

      About ALR Technologies Inc.
      The ALRT Health-E-Connect Disease Management System is designed to enhance compliance of prescribed therapies and report diagnostic data from a number of devices to health professionals for monitoring of patients. The System facilitates cost effective continued oversight of patients by authorized health professionals in-between visits to their physician. More information on ALR Technologies and its products can be found at http://www.alrt.com.
      Public Relations: 678-881-0002 Ext. 704 e-mail: info@alrt.com


      http://www.alrt.com/news_releases/news.asp?Press=5

      Lohnt da noch der Einstieg??
      Avatar
      schrieb am 16.09.09 08:58:05
      Beitrag Nr. 2 ()
      Antwort auf Beitrag Nr.: 37.985.144 von Huettenprofi am 15.09.09 19:34:07:keks:
      Avatar
      schrieb am 16.09.09 09:42:31
      Beitrag Nr. 3 ()
      Antwort auf Beitrag Nr.: 37.987.700 von Latinl am 16.09.09 08:58:05Freut mich, dass Du zu so einer aussagekräftigen Sprache fähig bist!:kiss:
      Meine Frage war ja schon sehr einfach gehalten!:O
      Avatar
      schrieb am 22.09.09 14:27:55
      Beitrag Nr. 4 ()
      Heute geht es up up up

      ALR Technologies Inc. Entry Into a Material Definitive Agreement

      ATLANTA, GA -- (Marketwire) -- 09/22/09 -- ALR Technologies (OTCBB: ALRT) announced in an 8K filing that on September 18, 2009, that Pari Respiratory Equipment, Inc.

      and ALR Technologies Inc. signed an agreement in which ALR Technologies licensed the Company's patented nebulizer compressor monitoring technology to Pari Respiratory Equipment, Inc. for the manufacturing and marketing of compliance-ready monitoring nebulizers worldwide.

      About ALR Technologies Inc.

      The ALRT Health-E-Connect Disease Management System is designed to enhance compliance of prescribed therapies and report diagnostic data from a number of devices to health professionals for monitoring of patients. The System facilitates cost effective continued oversight and care plan evaluation of patients by authorized health professionals in-between visits to their physician. More information on ALR Technologies and its products can be found at http://www.alrt.com.

      This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate," "expect," "anticipate," "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange Commission.

      Public Relations:

      678-881-0002 Ext. 704

      e-mail: Email Contact
      Avatar
      schrieb am 06.10.09 17:25:44
      Beitrag Nr. 5 ()
      Etwas spät aber heute scheint wieder ein Trend gen Norden zu kommen. Wird ja auch Zeit bei dem Potential. Viel wird sich aber nicht tun, bis die erste News über Umsatz kommmt, aber die kommt :eek:

      Trading Spotlight

      Anzeige
      InnoCan Pharma
      0,2170EUR +3,33 %
      Unfassbare Studie – LPT-Therapie bewahrt Patient vor dem Tod!mehr zur Aktie »
      Avatar
      schrieb am 03.11.09 19:02:03
      Beitrag Nr. 6 ()
      Was ist los mit ALRT? Keine Trades, keine News? Ist die Company tod?

      Gruß tomcat17
      Avatar
      schrieb am 08.01.10 13:06:19
      Beitrag Nr. 7 ()
      Gibt es irgendwas neues über ALR Technologies ?


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.
      Vielleicht ein Aufsteiger?